4//SEC Filing
Kim Na Yeon 4
Accession 0001104659-22-083645
CIK 0001638287other
Filed
Jul 27, 8:00 PM ET
Accepted
Jul 28, 4:03 PM ET
Size
14.2 KB
Accession
0001104659-22-083645
Insider Transaction Report
Form 4
Kim Na Yeon
Director10% Owner
Transactions
- Other
Common Stock
2022-07-26−1,445,267→ 2,890,533 total(indirect: Held by The E&Healthcare Investment Fund II)
Holdings
- 1,121,190(indirect: Held by The E&Healthcare Investment Fund No. 6)
Common Stock
- 1,864,799(indirect: Held by The E&Healthcare Investment Fund No. 7)
Common Stock
- 43,796
Common Stock
Footnotes (3)
- [F1]E&Healthcare Investment Fund II distributed 1,445,267 shares to its partners on a pro rata basis, for no consideration.
- [F2]Ms. Kim is the Chief Executive Officer of E&Investment, Inc., which is the sole general partner of The E&Healthcare Investment Fund II, The E&Healthcare Investment Fund No. 6 and The E&Investment Healthcare Fund No. 7, and as such, has voting and investment control over the shares held by E&Investment and its affiliated funds. The reporting person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein.
- [F3]Ms. Kim received a pro rata distribution from E&Healthcare Investment Fund II, of which she is a limited partner.
Issuer
NeuroBo Pharmaceuticals, Inc.
CIK 0001638287
Entity typeother
Related Parties
1- filerCIK 0001794779
Filing Metadata
- Form type
- 4
- Filed
- Jul 27, 8:00 PM ET
- Accepted
- Jul 28, 4:03 PM ET
- Size
- 14.2 KB